IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Therapix Biosciences LTD

CUSIP: 88339A203 | 26 institutional holders

Quarters

Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

Morgan Stanley436,189
0.0% of portfolio›$271
UBS Group AG41,428
0.0% of portfolio›$26
Millennium Management LLC14,200
0.0% of portfolio›$9
Envestnet Asset Management Inc10,018
0.0% of portfolio›$6
Wells Fargo & Company500
0.0% of portfolio›$0
Osaic Holdings, Inc.302
0.0% of portfolio›$0
Private Capital Group, LLC123
0.0% of portfolio›$0
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Morgan Stanley
436,189$2710.0%CoreLowNew York, NY2020-08-14
UBS Group AG
41,428$260.0%CoreMediumZurich, Switzerland2020-07-31
Millennium Management LLC
14,200$90.0%CoreVery HighNew York, NY2020-08-14
Envestnet Asset Management Inc
10,018$60.0%ETFLowBerwyn, PA2020-07-08
Wells Fargo & Company
500$00.0%CoreLowSan Francisco, CA2020-08-13
Osaic Holdings, Inc.
302$00.0%IndexLowScottsdale, AZ2020-08-14
Private Capital Group, LLC
123$00.0%N/AN/AWest Hartford, CT2020-08-13
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2020-08-13